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Abstract
Background: Detection of cell-free methylated DNA in plasma is a promising tool for tumour diagnosis and
monitoring. Due to the very low amounts of cell-free DNA in plasma, analytical sensitivity is of utmost importance.
The vast majority of currently available methods for analysing DNA methylation are based on bisulfite-mediated
deamination of cytosine. Cytosine is rapidly converted to uracil during bisulfite treatment, whereas 5-
methylcytosine is only slowly converted. Hence, bisulfite treatment converts an epigenetic modification into a
difference in sequence, amenable to analysis either by sequencing or PCR based methods. However, the recovery
of bisulfite-converted DNA is very poor.
Results: Here we introduce an alternative method for the crucial steps of bisulfite treatment with high recovery.
The method is based on an accelerated deamination step and alkaline desulfonation in combination with
magnetic silica purification of DNA, allowing preparation of deaminated DNA from patient samples in less than 2
hours.
Conclusions: The method presented here allows low levels of DNA to be easily and reliably analysed, a
prerequisite for the clinical usefulness of cell-free methylated DNA detection in plasma.
Background
Bisulfite induced modification of nucleic acids was ori-
ginally described in the 1970s [1-3] and since the emer-
gence of PCR and sequencing based detection methods
[4,5] bisulfite treatment has played a pivotal role in the
analysis of DNA methylation. In its original form it is a
time consuming and labour intensive procedure invol-
ving numerous experimental steps: DNA denaturation,
treatment with bisulfite for 12-16 hr, desalting and
desulfonation with NaOH, and finally neutralisation and
desalting. Recently published improvements include an
accelerated deamination step, cutting down incubation
time from 12-16 hr to 40 min, achieved by the use of a
more concentrated bisulfite solution at higher tempera-
tures [6,7]. The accelerated and the conventional meth-
ods have been explicitly compared by Genereux et al.
[8]. The accelerated method leads to a more homoge-
nous conversion of cytosine both across sites and mole-
cules, conceivably due to facilitation of DNA
denaturation in concentrated bisulfite solution at 70°C.
Hence, inappropriate conversion of 5-methylcytosine, a
result of prolonged bisulfite exposure of molecules with
complete conversion of cytosine, is more controllable.
In addition to deamination of cytosine, bisulfite also
induces chain breakage of DNA [9]. The DNA degrada-
tion caused by bisulfite treatment results in DNA frag-
ments of an average length of approximately 600
nucleotides [10]. Real-time PCR based methods rely on
amplification of short DNA fragments of 60-150 nucleo-
tides. Hence, the use of real-time PCR limits the direct
influence of fragmentation on the detection step. How-
ever, fragmentation affects recovery of DNA after bisul-
fite treatment. If the starting material is < 200 ng DNA,
more than 95% of bisulfite-treated DNA is lost during
desulfonation and purification with standard procedures
[10,11]. This is a serious problem, especially when ana-
lysing material with very small amounts of DNA avail-
able, such as plasma with a median level of 10 ng cell-
free DNA/ml in normal controls [11]. Although, the
level of cell-free DNA is slightly increased in cancer
patients [12], the combination of minute amounts of
cell-free DNA in plasma and poor recovery after
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issues. Improved recovery can be achieved by incorpora-
tion of DNA into agarose prior to bisulfite treatment.
Denaturation, deamination and desulfonation are subse-
quently carried out on DNA embedded in the agarose
beads [13]. This method has successfully been used to
analyse DNA from microdissected cells [14]. Embedding
of DNA in agarose is, however, a labour intensive
method not amneable to automation, limiting its suit-
ability in a clinical setting.
The ability to easily analyse sparse amounts of methy-
lated DNA is a prerequisite for the usefulness of cell-
free methylated DNA in plasma as a diagnostic or prog-
nostic marker for cancer. An enormous amount of work
has been put into identification of putative methylated
DNA biomarkers and optimisation of the final analytical
step: the detection of bisulfite-treated DNA. Hence, sev-
eral reliable methods enabling the detection of minute
amounts of bisulfite-treated DNA have been published
[15-20]. Most recently the qMAMBA protocol (quantita-
tive Methylation Analysis of Minute DNA amounts after
whole Bisulfitome Amplification) has been developed,
elegantly addressing several of the issues related to
methylation analysis of samples with very low amounts
of starting material [19,20]. However, as stated by Pali-
wal et al. [19] the most critical determinant of success-
ful application of qMAMBA is the quality and quantity
of starting material, emphasising the importance of the
initial steps of the analysis: DNA isolation and bisulfite-
treatment. Very few studies have addressed the loss of
analytical sensitivity associated with the bisulfite treat-
ment itself. Here we present a fast and reliable method,
optimised in order to achieve high recovery, for the
detection of methylated DNA from biospecimens with
sparse amounts of DNA.
Methods
Bisulfite treatment
Cell-free DNA was isolated from 1 ml EDTA plasma on
the EasyMAG nucleic acid purification platform (Bio-
meriéux), using the recommended protocol for plasma.
Bisulfite treatment was based on previously published
accelerated methods [6,7], with some modifications. The
optimised protocol is as follows: 50 μlo f1 0M( N H 4)
HSO3-NaHSO3 solution were added to 25 μl of purified
DNA in PCR strips. The strips were placed in a PCR
machine, heated for 10 min at 90°C and subsequently
cooled to room temperature. The solution containing
the DNA-bisulfite adducts were purified on the Easy-
MAG nucleic acid purification platform (Biomeriéux)
using the off-board procedure according to manufac-
ture’s instructions, except for changes made to lysis buf-
fer, extraction buffers A and B, and elution buffer. To
ensure high recovery, 2 ml EasyMAG lysis buffer were
replaced by a mix of 0.5 ml ethanol and 0.5 ml H2O,
whereas extraction buffers A and B (Biomeriéux) both
were replaced by 33% ethanol in H2O. For this extrac-
tion 25 μl magnetic beads were used. Finally, DNA was
eluted in 25 μl 10 mM KOH. The alkaline solution in
combination with the heatingo c c u r r i n gd u r i n ge l u t i o n
leads to desulfonation of DNA-bisulfite adducts.
DNA quantitation
To investigate recovery of bisulfite-treated DNA, 3 dif-
ferent primersets, all sharing the same detection probe,
were designed: MLH1UF and MLH1 R detect DNA
regardless of deamination [11]. MLH1 DF and MLH1 R
detect deaminated DNA, whereas MLH1 UDF and
MLH1 UDR detect undeaminated DNA (Table 1 and
Figure 1B).
Dynamics of deamination
Three μg of colon tissue DNA were deaminated in tri-
plicate for different time durations, purified and desulfo-
nated. Five ul DNA were used for quantitation, the
residual DNA was used for HPLC. This DNA was
digested with 1 unit nuclease P1 (Sigma) and 10 units
DNAseI (Roche) in a total volume of 40 μl at 37°C over-
night [21]. Two units alkaline phosphatase (Roche) were
added and the mix was incubated at 37°C for 2 hours.
Before injection, 50 μl of 50 mM sodium acetate pH 4.8
were added. Twentyfive μl were injected into a cation
exchange column (Luna SCX, Phenomenex) in a Dionex
Ultimate 3000 HPLC system. The mobile phase con-
sisted of 5% acetonitrile in a gradient of 50 mM sodium
acetate from 2% to 75%. Deoxynucleosides were
detected at 260 nm. For calculation of relative amounts
of nucleosides the following extinction coefficients have
been used: dU (9.2*10
3 M
-1 cm
-1), dT (9.2*10
3 M
-1 cm
-
1), dG (11.7*10
3 M
-1 cm
-1), dA (15.4*10
3 M
-1 cm
-1), dC
(7.5*10
3 M
-1 cm
-1) and dmC (7.5*10
3 M
-1 cm
-1).
Measurement of analytical sensitivity
The sensitivity of methylation detection was assessed by
analysing a dilution series of Universal Methylated DNA
(Chemicon) in purified plasma DNA. After deamination
the recovered DNA was quantified in triplicate for
methylated RASFF1A and unmethylated RASSF1A using
primers and probes listed in Table 1.
The efficiency of the deamination of unmethylated
cytosines and the recovery of both methylated and
unmethylated DNA fragments following bisulfite-treat-
ment were elucidated using the hemimethylated MEST
promoter as a model. Plasma DNA was diluted to con-
centrations of 10, 5, 2.5 and 1.25 genome equivalents pr.
25 μl of methylated and unmethylated MEST, respec-
tively. Twentyfour samples of each dilution were deami-
nated and used in methylation-specific real-time PCR
Pedersen et al. BMC Molecular Biology 2012, 13:12
http://www.biomedcentral.com/1471-2199/13/12
Page 2 of 8with MEST UM primers and probe and MEST M pri-
mers and probe, respectively. Primer and probe
sequences are listed in Table 1. The detection frequen-
cies were calculated as the percentage of positive reac-
tions out of the 24 replicates.
Measurement of recovery
Recovery of deaminated plasma DNA was investigated
using DNA from 24 plasma samples. DNA from 1 ml of
each sample was extracted and eluted in 75 ul. Twentyf-
ive ul were deaminated and extracted, another 25 ul
were mock-deaminated (no heating) and extracted,
whereas the residual was used for quantitation using
MLH1 primers described in Table 1.
Results and discussion
Extensive optimisation of a previously published bisulfite
treatment method [6,7] has led to the development of a
fast bisulfite treatment with high recovery and potential
for semi-automation. Optimisation involved the purifica-
tion procedure after deamination in order to facilitate
recovery of the fragmented DNA resulting from bisulfite
treatment. This part of the procedure has previously
been identified as a critical step [10]. Optimisation of
the purification method had a pronounced effect on
recovery, especially replacement of lysis and extraction
buffers with ethanol increased recovery. In addition,
adjustments of the reaction time were made. During
optimisation the dynamics of the reaction had to be
measured in order to ensure optimal conversion of cyto-
sine and limited conversion of methyl-cytosine.
In the discovery phase bisulfite treatment, cloning and
sequencing of individual clones is the method of choice,
because of the detailed information of methylation sta-
tus of individual CpG sites achieved. This procedure,
from primer design to presentation of results has been
described in detail [22]. When sequencing individual
clones, complete deamination of unmethylated cytosine
is extremely important. Incomplete deamination of
unmethylated cytosine could lead to a false positive
result. Typically more than one methylated CpG site is
investigated when using methylated DNA as a tumour
marker. Hence, this set up is less likely to yield a false
positive result due to incomplete conversion of cytosine.
However, if the reaction is poorly optimised and conver-
sion of cytosine is far from complete, real-time detection
will fail, leading to apparently low recovery. Therefore,
while optimising recovery, dynamics of the reaction
have been extensively monitored using both a real-time
PCR based and a HPLC based method. The results of
optimisation of the reaction time are shown in Figures 1
and 2. After 5 min of deamination, no undeaminated
Table 1 Primer and beacon sequences
Primer/beacon Sequence
MLH1 UF TGT GAI AAA AAA TGT GAA GGG
MLH1 DF GAA GAT ATT AGA TTT TAT GGG TTA TTT
MLH1 R CAA CTI AAT TTT AAC AAA ATA ATC T
MLH1 UDF ACC AGA TTT TAT GGG TCA TCC
MLH1 UDR TTC TAT TAA CGT ACG GAC G
MLH1 beacon (FAM)CGC GAA TGT GGA AGG AAA AGT GAG TGT CGC(Dabcyl)
RASSF1A MF GGG AGG CGT TGA AGT C
RASSF1A MR CCC GTA CTT CGC TAA CTT TAA ACG
RASSF1A M beacon (HEX)CGC GAT TCG + TT + C G + GT TCG CTC GCG(Dabcyl)
RASSF1A UMF TTT TGT ATT TAG GTT TTT ATT GTG T
RASSF1A UMR CCC ATA CTT CAC TAA CTT TAA ACA
RASSF1A UM beacon (FAM)CGC GAG + TT + TG + GTT + TG + TG + TTTC GCG(Dabcyl)
MEST MF TGT CGC GGT AAT TAG TAT ATT TC
MEST MR AAC CCG CGC AAA ACG ACG
MEST M beacon (HEX)CGC GAT TAC + GAA AC + G CAA CTA CCG ATC GCG(Dabcyl)
MEST UMF GTG TTG TTG TGG TAA TTA GTA TAT TTT
MEST UMR AAC CCA CAC AAA ACA ACA CCA
MEST UM beacon (FAM)CGC GAG + TA + G T + TG + TG + T TT + T GTT CGC G(Dabcyl)
MLH1 UF and MLH1 R concurrently amplify deaminated and undeaminated MLH1 promoter. MLH1 DF and MLH1 R amplify deaminated MLH1. MLH1 UDF and
MLH1 UDR amplify undeaminated MLH1 promoter. A common molecular beacon (MLH1 beacon) was used for detection of the 3 products. RASSF1A MF and
RASSF1A MR amplify methylated RASSF1A. RASSF1A UMF and RASSF1A UMR amplify unmethylated RASSF1A. Methylated and unmethylated products were
detected by RASSF1A M beacon and RASSF1A UM beacon, respectively. MEST MF and MEST MR amplify methylated MEST, whereas MEST UMF and MEST UMR
amplify unmethylated MEST. Methylated and unmethylated products were detected by MEST M beacon and MEST UM beacon, respectively. To ensure high
specificity the probes designed to discriminate between methylated and unmethylated products contain LNA nucleotides at positions marked with +.
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Page 3 of 8Figure 1 Monitoring of reaction dynamics by real-time PCR. A) Monitoring of the deamination reaction as a function of deamination time
using primers designed for an unmethylated part of the MLH1 promoter. Three different primer sets were used. The first set (MLH1 UF and
MLH1 R) binds to areas with no cytosines, and hence amplify both deaminated and undeaminated DNA. However, since deamination creates 2
uncomplementary DNA strands, only one strand of the deaminated DNA can function as a template. The second set (MLH1 DF and MLH1 R)
cytosine has been replaced by thymine making it specific to deaminated DNA. The third set (MLH1 UDF and MLH1 UDR) contains cytosines
making it specific to undeaminated DNA. Real-time PCR detection of the 3 products was performed with a common molecular beacon (MLH1
beacon). B) Binding sites of beacon and primers used are shaded. Top strand is the undeaminated DNA sequencing. Bottom strand is the
deaminated sequence. A horizontal line between the two strands illustrates no difference in sequence, “:” marks the positions of cytosine
converted to uracil during deamination, and “+” marks the positions of CpG dinucleotides. Primer sequences can be found in Table 1. The
universal primers, MLH1 UF and MLH1 R, contain Inosine at one position each.
Pedersen et al. BMC Molecular Biology 2012, 13:12
http://www.biomedcentral.com/1471-2199/13/12
Page 4 of 8product was detectable by real-time PCR (Figure 1). The
beacon and primers used in this experiment have been
designed in order to give as comparable reaction
conditions as possible. The overlap in the probe and pri-
mers used for the different reactions gives less stringent
differentiation compared with methylation specific real-
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Figure 2 Monitoring of reaction dynamics by HPLC. A) The distribution of nucleosides as measured by HPLC depicted as a function of
deamination time. The levels of Gs, As and methylated Cs remain constant throughout the reaction. Cs are converted to Us as the deamination
progresses. B) Examples of HPLC chromatograms at different deamination times (0 min., 10 min., 15 min. and 30 min.).
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Page 5 of 8time PCR, where both primers and probes generally are
specific for either the methylated or the unmethylated
sequence. However, no cross-reactivity is observed in
our experiment. The primers used to discriminate
between undeaminated and deaminated product cover 5
cytosines (Figure 1). Primer binding mainly depends on
the conversion of the 2 cytosines in the 3’ end of the
primer binding site. Therefore complete conversion of
cytosine appears to be achieved faster when measured
by real-time PCR compared with HPLC, where a limited
amount of cytosines (< 1%) is detectable after 10 min
deamination, and none after 15 min (Figure 2). Longer
deamination time than 10 min results in reduced detec-
tion of both deaminated and undeaminated DNA, since
the purpose is to optimise this protocol in order to
achieve the best possible recovery of bisulfite treated
DNA, the deamination time was set to 10 min.
In addition to incomplete conversion of cytosine, inap-
propriate conversion of methylated cytosine could lead
to reduced sensitivity when detecting methylated DNA.
The real-time PCR based experiment (Figure 1) does
not address the problem of over-conversion, since the
primers and the probe are designed to an unmethylated
part of MLH1. Methylated cytosine is monitored by the
HPLC procedure (Figure 2). However, methylated cyto-
sine constitutes only a small fraction of the nucleotides.
Therefore, to further elucidate the reaction dynamics
and recovery of both methylated and unmethylated
DNA, the hemimethylated MEST promoter has been
used as a naturally occurring model system. Comparable
detection of methylated and un-methylated MEST was
observed, when calculating detection frequency as the
percentage of positive reactions out of the 24 replicates
(Figure 3).
Similar experiments monitoring the dynamics of the
reaction were carried out when changing other para-
meters, such as reaction temperature and denaturation
of DNA prior to bisulfite treatment (data not shown).
Denaturation of DNA did not affect recovery or conver-
sion in the current study, even though this step has
been pointed out to be critical, and different denaturants
such as NaOH, urea and formamide have been used.
Formamide was shown to have a great effect when
working on DNA from formalin-fixed paraffin-
embedded tissue [23]. The lack of need of denaturants
in the protocol presented here possibly reflects the
denaturating effect of the high concentration of bisulfite
and high temperature used for deamination.
Further investigation of the analytical sensitivity of the
newly optimised procedure was carried out using a dilu-
tion of universally methylated DNA in purified plasma
DNA. RASSF1A was used as a model system. RASSF1A
is fully methylated in the universally methylated DNA
and unmethylated in the plasma DNA sample. Table 2
illustrates that low copy numbers of methylated
RASSF1A promotor region was reliably detected in a
background of approximately 2000 copies of unmethy-
lated DNA.
Recovery of deaminated DNA using the optimised
method was compared with recovery of DNA in a
matrix of deamination reagents. Re-extraction of DNA
in a matrix of deamination reagents results in a recovery
of 83% whereas recovery of deaminated DNA is 60%
(Table 3). The likely explanation of the difference is the
unavoidable degradation of DNA during deamination.
Markers such as septin 9 hold great promise of clinical
usefulness. The improved recovery rate of the bisulfite
reaction achieved by the presented protocol may further
improve its potential in a clinical setting, and avoid some
of the expensive and labour intensive steps such as the
need to purify multiple plasma samples in parallel and
subsequent pooling of DNA [16,24]. Indeed, the initial
promising reports on the potential of septin 9 have been
strengthened by a recent report employing silica based
magnetic DNA purification [25]. This work by deVos et
al. address the problem of poor recovery, and the reported
recovery rates are comparable to our results. However, the
quantitation of DNA prior to and after bisulfite treatment
is based on two different real-time PCR assays. We have
employed a real-time PCR assay capable of detecting both
treated and untreated DNA [11] allowing the same assay
to be used for measuring DNA levels both pre and post
bisulfite treatment resulting in improved accuracy
Conclusions
In this report we present a fast and reliable bisulfite
treatment with high recovery from samples with minute
amounts of DNA (< 0.1 ng/ml), opening the possibility
of improving diagnostic sensitivity of the wide-range of
potential markers already identified. The major improve-
ment in recovery is achieved by alterations in the
Figure 3 Detection of the hemi-methylated MEST promoter.
Recovery of methylated and unmethylated MEST, measured in a
dilution series of cell-free DNA from plasma. Each reaction was run
24 times, and the detection frequency is calculated as the
percentage positive reactions.
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Page 6 of 8purification of bisulfite treated DNA. In addition, the
method presented here allows preparation of deami-
nated DNA from patient samples in less than 2 hours.
The development of this method amenable to semi-
automation should considerably enhance the usefulness
of methylation analysis in a clinical setting.
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